HOWARD HUGHES MEDICAL INSTITUTE - TRANSDIGM GROUP INC ownership

TRANSDIGM GROUP INC's ticker is TDG and the CUSIP is 893641100. A total of 301 filers reported holding TRANSDIGM GROUP INC in Q2 2014. The put-call ratio across all filers is 1.52 and the average weighting 0.8%.

About TRANSDIGM GROUP INC

TransDigm Group Inc. is a leading designer, producer, and supplier of highly engineered aircraft components for use in commercial and military aircraft. The company's products include mechanical and electro-mechanical actuators and controls, ignition systems and engine technology, and safety restraint systems. TransDigm's products are used in a wide range of aircraft, including commercial airliners, military fighter jets, and helicopters.

TransDigm has a strong reputation for quality and innovation, and the company's products are highly regarded by customers in the aerospace industry. The company has a long history of successful acquisitions, which has helped to expand its product portfolio and customer base.

Despite the challenges posed by the COVID-19 pandemic, TransDigm has continued to perform well. The company reported strong financial results for the first quarter of fiscal year 2021, with net sales of $1.3 billion and net income of $193 million. The company's strong financial position has allowed it to continue investing in research and development, as well as pursuing strategic acquisitions.

Looking ahead, TransDigm is well-positioned to benefit from the ongoing growth in the aerospace industry. The company's focus on innovation and quality, combined with its strong financial position, make it a compelling investment opportunity for stock market investors.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
HOWARD HUGHES MEDICAL INSTITUTE ownership history of TRANSDIGM GROUP INC
ValueSharesWeighting
Q2 2016$437,000
+31.2%
1,658
+9.6%
0.15%
+101.4%
Q1 2016$333,000
-3.8%
1,5130.0%0.07%
+37.7%
Q4 2015$346,000
+160.2%
1,513
+142.5%
0.05%
+112.0%
Q3 2015$133,000
-34.2%
624
-42.8%
0.02%
-13.8%
Q1 2014$202,000
+35.6%
1,091
+18.1%
0.03%
+31.8%
Q4 2013$149,000
+0.7%
924
-13.4%
0.02%
-4.3%
Q3 2013$148,000
+7.2%
1,067
+21.0%
0.02%
-48.9%
Q2 2013$138,0008820.04%
Other shareholders
TRANSDIGM GROUP INC shareholders Q2 2014
NameSharesValueWeighting ↓
Berkshire Partners LLC 1,021,471$637,980,00052.91%
Ampfield Management, L.P. 69,850$43,626,00038.06%
Altarock Partners 1,326,182$828,293,00022.34%
BRX Global LP 43,213$26,990,00021.55%
Anabranch Capital Management, LP 58,424$36,490,00020.94%
Stockbridge Partners LLC 1,554,497$970,892,00020.01%
Oakcliff Capital Partners, LP 55,698$34,787,00015.40%
East Coast Asset Management, LLC. 72,833$45,489,00010.67%
Deccan Value Investors L.P. 426,142$266,156,00010.53%
Atalan Capital Partners, LP 263,000$164,262,00010.24%
View complete list of TRANSDIGM GROUP INC shareholders